Telemonitoring in diabetes: evolution of concepts and technologies, with a focus on results of the more recent studies
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
This is a narrative review of telemonitoring (remote monitoring) projects and studies within the field of diabetes, with a focus on results of the more recent studies. Since the beginning of the 1990s, several telemedicine projects and studies focused on type 1 and type 2 diabetes. Over the last 5 years, numerous telemedicine projects based on connected objects and new information and communication technologies (ICT) (elements defining telemedicine 2.0) have emerged or are still under development. Two examples are the DIABETe and Telesage telemonitoring project which perfectly fits within the telemedicine 2.0 framework – the first to include artificial intelligence (AI) with MyPredi TM and Diabeo TM. Mainly, these projects and studies show that telemonitoring diabetic result in: improvements in control of blood glucose (BG) level and significant reduction in HbA1c (e.g., for Telescot et TELESAGE studies); positive impact on co-morbidities (arterial hypertension, weight, dyslipidemia) (e.g., for Telescot and DIABETe studies); better patient’s quality of life (e.g., for DIABETe study); positive impact on appropriation of the disease by patients and/or greater adherence to therapeutic and hygiene-dietary measures (e.g., The Utah Remote Monitoring Project); and at least, good receptiveness by patients and their empowerment. To date, the magnitude of its effects remains debatable, especially with the variation in patients’ characteristics (e.g., background, ability for self-management, medical condition), samples selection and approach for the treatment of control groups. All of the recent studies have been classified as “Moderate” to “High”.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Steventon, A., Bardsley, M., Billings, J., Dixon, J., Doll, H., Hirani, S., Cartwright, M., Rixon, L., Knapp, M., Henderson, C., et al. (2012) · BMJ · doi:10.1136/bmj.e3874 · Cited by 583
Quinn, C. C., Clough, S. S., Minor, J. M., Lender, D., Okafor, M. C., & Gruber-Baldini, A. (2008) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0283 · Cited by 406
Haw, J. S., Galaviz, K. I., Straus, A. N., Kowalski, A. J., Magee, M. J., Weber, M. B., Wei, J., Narayan, K. M. V., & Ali, M. K. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.6040 · Cited by 354 · cited 1×
“Along with diabetes, CHF and COPD are among the most common diseases in developed countries, and thus represent a major public health concern for society [1, 2].”
BackgroundDefinition of Health 2.0 and Medicine 2.0: A Systematic Review
Van De Belt, T. H., Engelen, L. J., Berben, S. A., & Schoonhoven, L. (2010) · Journal of Medical Internet Research · doi:10.2196/jmir.1350 · Cited by 351
Charpentier, G., Benhamou, P.-Y., Dardari, D., Clergeot, A., Franc, S., Schaepelynck-Belicar, P., Catargi, B., Melki, V., Chaillous, L., Farret, A., et al. (2011) · Diabetes Care · doi:10.2337/dc10-1259 · Cited by 292
Telecare for Patients With Type 1 Diabetes and Inadequate Glycemic Control
Montori, V. M., Helgemoe, P. K., Guyatt, G. H., Dean, D. S., Leung, T. W., Smith, S. A., & Kudva, Y. C. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1088 · Cited by 169
Lee, P. A., Greenfield, G., & Pappas, Y. (2018) · BMC Health Services Research · doi:10.1186/s12913-018-3274-8 · Cited by 162
Web-based collaborative care for type 1 diabetes: a pilot randomized trial
McCarrier, K. P., Ralston, J. D., Hirsch, I. B., Lewis, G., Martin, D. P., Zimmerman, F. J., & Goldberg, H. I. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0063 · Cited by 117
Wu, C., Wu, Z., Yang, L., Zhu, W., Zhang, M., Zhu, Q., Chen, X., & Pan, Y. (2018) · Medicine · doi:10.1097/md.0000000000012962 · Cited by 86
Hu, Y., Wen, X., Wang, F., Yang, D., Liu, S., Li, P., & Xu, J. (2019) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x18776823 · Cited by 57
Cited by
Varma, N., Cygankiewicz, I., Turakhia, M. P., Heidbuchel, H., Hu, Y.-F., Chen, L. Y., Couderc, J.-P., Cronin, E. M., Estep, J. D., Grieten, L., et al. (2021) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.120.009204 · Cited by 74
Steenkamp, D., Eby, E. L., Gulati, N., & Liao, B. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/1932296821997923 · Cited by 33
Cai, J., Xu, H., Jiang, S., Sung, J., Sawhney, R., Broadley, S., & Sun, J. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110727 · Cited by 8
Metadata
- Authors
- Andrès, E., Service de Médecine Interne, D. E. M. M. D. L. C. M. B., Equipe de recherche EA 3072 «Mitochondrie, S. O. E. P. M., Emmanuel Andrès, S. D. M. I., Meyer, L., Service d’Endocrinologie et de Diabétologie de la Clinique Médicale B, H. U. D. S., Zulfiqar, A.-A., Equipe de recherche EA 3072 «Mitochondrie, S. O. E. P. M., Service de Médecine Interne, G. E. T., Hajjam, M., Predimed Technology, S., Talha, S., Equipe de recherche EA 3072 «Mitochondrie, S. O. E. P. M., Service de Physiologie et d’Explorations Fonctionnelles, H. U. D. S., Bahougne, T., Service d’Endocrinologie et de Diabétologie de la Clinique Médicale B, H. U. D. S., Ervé, S., Centre d’expertise des Technologies de l’Information et de la Communication pour l’autonomie (CENTICH) et Mutualité Française Anjou-Mayenne (MFAM), A., Hajjam, J., Centre d’expertise des Technologies de l’Information et de la Communication pour l’autonomie (CENTICH) et Mutualité Française Anjou-Mayenne (MFAM), A., Doucet, J., Service de Médecine Interne, G. E. T., Jeandidier, N., Service d’Endocrinologie et de Diabétologie de la Clinique Médicale B, H. U. D. S., Hajjam El Hassani, A., & Equipe de recherche EA 4662 «Nanomédecine, I.
- Venue
- Journal of Medicine and Life
- Published
- 2019-07
- Volume
- 12
- Issue
- 3
- Pages
- 203-214
- ISSN
- 1844-122X (ISSN-L)
- 1844-3117
- OpenAlex
- W2985324159
- Cited by
- 68
- References
- 11
- FWCI
- 7.90
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Telemonitoring in diabetes: evolution of concepts and technologies, with a focus on results of the more recent studies. https://app.cochat.ai/papers/10.25122/jml-2019-0006
- The paper
- Andrès, E., Service de Médecine Interne, D. E. M. M. D. L. C. M. B., Equipe de recherche EA 3072 «Mitochondrie, S. O. E. P. M., Emmanuel Andrès, S. D. M. I., Meyer, L., Service d’Endocrinologie et de Diabétologie de la Clinique Médicale B, H. U. D. S., Zulfiqar, A.-A., Equipe de recherche EA 3072 «Mitochondrie, S. O. E. P. M., Service de Médecine Interne, G. E. T., Hajjam, M., Predimed Technology, S., Talha, S., Equipe de recherche EA 3072 «Mitochondrie, S. O. E. P. M., Service de Physiologie et d’Explorations Fonctionnelles, H. U. D. S., Bahougne, T., Service d’Endocrinologie et de Diabétologie de la Clinique Médicale B, H. U. D. S., Ervé, S., Centre d’expertise des Technologies de l’Information et de la Communication pour l’autonomie (CENTICH) et Mutualité Française Anjou-Mayenne (MFAM), A., Hajjam, J., . . . Equipe de recherche EA 4662 «Nanomédecine, I. (2019). Telemonitoring in diabetes: evolution of concepts and technologies, with a focus on results of the more recent studies. Journal of Medicine and Life. https://doi.org/10.25122/jml-2019-0006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.